Concepedia

Yvette Robbins

YR

21

Publications

1.4K

Citations

16

H-Index

2017

Active since

Affiliations

National Cancer Institute(Current)

National Institute on Deafness and Other Communication Disorders

National Institutes of Health

Center for Cancer Research

Johns Hopkins Medicine

Yvette Robbins is an author at National Cancer Institute specializing in medicine, immunology, and tumor microenvironment.

ORCID

Top concepts

Publications per year

2017–2024

21

Publications

21

Inhibition of MDSC Trafficking with SX-682, a CXCR1/2 Inhibitor, Enhances NK-Cell Immunotherapy in Head and Neck Cancer Models

Sarah Greene, Yvette Robbins, Wojciech K. Mydlarz et al. · Clinical Cancer Research · 2019 · 263 citations · Full text

Inhibiting myeloid-derived suppressor cell trafficking enhances T cell immunotherapy

Lillian Sun, Paúl E. Clavijo, Yvette Robbins et al. · JCI Insight · 2019 · 228 citations · Full text

, , +18

PD-L1 targeting high-affinity NK (t-haNK) cells induce direct antitumor effects and target suppressive MDSC populations

Kellsye P. Fabian, Michelle R. Padget, Renee N. Donahue et al. · Journal for ImmunoTherapy of Cancer · 2020 · 143 citations · Full text

γδ T Cells Are Required for the Induction of Sterile Immunity during Irradiated Sporozoite Vaccinations

Irfan Zaidi, Hama Diallo, Solomon Conteh et al. · The Journal of Immunology · 2017 · 112 citations · Full text

Neoadjuvant PD-1 Immune Checkpoint Blockade Reverses Functional Immunodominance among Tumor Antigen–Specific T Cells

Jay Friedman, Ellen Moore, Paul Zolkind et al. · Clinical Cancer Research · 2019 · 78 citations · Full text

Rows per page

1–5 of 21